Emerging Treatment Modalities in Metastatic Breast Cancer: Highlights from SABCS 2022 and Beyond

home / insights / emerging-treatment-modalities-in-metastatic-breast-cancer-highlights-from-sabcs-2022-and-beyond

Komal Jhaveri, MD, FACP, and Paolo Tarantino, MD, discuss updates in the treatment of metastatic breast cancer (mBC) from SABCS 2022 and other recent meetings, and how to best incorporate recent data into clinical practice.

Overview of ER+/HER2- Metastatic Breast Cancer (mBC)

EP. 1: Overview of ER+/HER2- Metastatic Breast Cancer (mBC)

Paolo Tarantino, MD;Komal Jhaveri, MD, FACP
January 30th 2023
Standards of Care in the Frontline Treatment of ER+/HER2- mBC

EP. 2: Standards of Care in the Frontline Treatment of ER+/HER2- mBC

Paolo Tarantino, MD;Komal Jhaveri, MD, FACP
January 30th 2023
Use of Second-Generation Oral SERDs in ER+/HER2- mBC

EP. 3: Use of Second-Generation Oral SERDs in ER+/HER2- mBC

Paolo Tarantino, MD;Komal Jhaveri, MD, FACP
February 7th 2023
The Role of Capivasertib in ER+/HER- mBC

EP. 4: The Role of Capivasertib in ER+/HER- mBC

Paolo Tarantino, MD;Komal Jhaveri, MD, FACP
February 13th 2023
Standard Practices for the Management of Triple-Negative Breast Cancer (TNBC)

EP. 5: Standard Practices for the Management of Triple-Negative Breast Cancer (TNBC)

Paolo Tarantino, MD;Komal Jhaveri, MD, FACP
February 22nd 2023
The Role of ADCs in the Treatment of TNBC

EP. 6: The Role of ADCs in the Treatment of TNBC

Paolo Tarantino, MD;Komal Jhaveri, MD, FACP
February 22nd 2023
Investigational ADCs for Treatment of TNBC

EP. 7: Investigational ADCs for Treatment of TNBC

Paolo Tarantino, MD;Komal Jhaveri, MD, FACP
March 2nd 2023
Emerging Concepts in mBC Treatment

EP. 8: Emerging Concepts in mBC Treatment

Paolo Tarantino, MD;Komal Jhaveri, MD, FACP
March 2nd 2023